Die Bedeutung freier Fettsäuren für die Regulation der hepatischen Glukoneogenese des Menschen / Dissertant: Harald Stingl
eng: Healthy, lean subjects (n=6) were infused with lipid/heparin (FFA: 2.8 #+- # 0.3 mM; glycerol: 0.5 #+-# 0.1 mM) and glycerol during 9 hours (= control; 0.6 #+-# 0.1 mM; 0.5 #+-# 0.0 mM). During lipid infusion, plasma insulin concentrations rose by #approx#50 % (p;0.05), but neither endogenous...
Saved in:
VerfasserIn: | |
---|---|
Place / Publishing House: | [2000] |
Year of Publication: | 2000 |
Language: | German |
Subjects: | |
Online Access: | |
Physical Description: | VI, 125 Bl.; Ill., graph. Darst. |
Notes: | Zsfassung in engl. Sprache |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
LEADER | 03284nam#a2200373zc#4500 | ||
---|---|---|---|
001 | 990000320010504498 | ||
005 | 20230918133735.0 | ||
007 | tu | ||
008 | 000315|2000####|||######m####|||#|#ger#c | ||
009 | AC02934439 | ||
015 | |a OeBB |2 oeb | ||
035 | |a (AT-OBV)AC02934439 | ||
035 | |a AC02934439 | ||
035 | |a (Aleph)002931466ACC01 | ||
035 | |a (DE-599)OBVAC02934439 | ||
035 | |a (EXLNZ-43ACC_NETWORK)990029314660203331 | ||
040 | |a ZBM |b ger |d AGBA |e rakwb | ||
041 | |a ger | ||
044 | |c XA-AT | ||
084 | |a QU 90 |2 nlm | ||
084 | |a WK 810 |2 nlm | ||
100 | 1 | |a Stingl, Harald Alexander |4 aut | |
245 | 1 | 0 | |a Die Bedeutung freier Fettsäuren für die Regulation der hepatischen Glukoneogenese des Menschen |c Dissertant: Harald Stingl |
264 | 1 | |c [2000] | |
300 | |a VI, 125 Bl. |b Ill., graph. Darst. | ||
500 | |a Zsfassung in engl. Sprache | ||
502 | |a Wien, Univ., Diss., 2000 | ||
520 | |a eng: Healthy, lean subjects (n=6) were infused with lipid/heparin (FFA: 2.8 #+- # 0.3 mM; glycerol: 0.5 #+-# 0.1 mM) and glycerol during 9 hours (= control; 0.6 #+-# 0.1 mM; 0.5 #+-# 0.0 mM). During lipid infusion, plasma insulin concentrations rose by #approx#50 % (p;0.05), but neither endogenous glucose production (EGP, estimated with D-[6,6-"2H_2]-glucose) nor fractional gluconeogenesis (GNG, "2H enrichments in C5/C2 of blood glucose following "2H_2O ingestion) were different from control studies. During somatostatin-insulin-glucagon clamp tests at postabsorptive plasma insulin (#approx#35 pM) and glucagon (#approx#90 ng/ml) concentrations, plasma glucose increased by #approx#50 % (p;0.005) during lipid infusion. Rates of EGP remained unchanged (#approx#9.5 #mu#mol*kg"-"1min"-"1). GNG was 62 #+-# 5 % (lipid) and 60 #+-# 6 % (glycerol) at 0 min and dose (p;0.005) to 74 #+-# 3 % during lipid infusion (540 min, p;0.05 vs. glycerol: 64 #+-# 4 %). In a second study, healthy subjects were infused with lipid/heparin (FFA: 2.2 #+-# 0.1 mM; glycerol: 0.5 #+-# 0.03 mM; n=7) , glycerol (0.4 #+-# 0.1 mM; 1.5 #+-# 0.2 mM, n=5) and saline (0.5#+-#0.1 mM; 0.2 #+-# 0.02 mM; n=7). Rates of GNG were calculated by subtracting rates of net glycogen breakdown (decrease of liver glycogen, 9 h, "1"3C NMR spectroscopy) from EGP. EGP decreased by #approx#25 % during lipid and saline, but not during glycerol infusion (p;0.001 vs. lipid, saline). Elevation of plasma FFA or glycerol increased GNG to 96 #+-# 2 % (p;0.001) and 86 #+-# 3 % (p;0.01 vs. saline: 70 #+-# 4 %), respectively. When the lipid-induced rise of portal vein insulin concentrations (p;0.05) was matched employing somatostatin-insulin-glucagon clamps (n=5), GNG (66 #+- # 3 %) did not differ from saline studies. In conclusion, FFA elevation markedly augments GNG without affecting EGP. This effect is neither due to (i) the lipid-induced rise in insulin secretion nor to (ii) increased glycerol availability alone, since very high glycerol concentrations were required for a comparable increase in fractional GNG. | ||
689 | 0 | 0 | |a Leber |D s |0 (DE-588)4034933-0 |
689 | 0 | 1 | |a Gluconeogenese |D s |0 (DE-588)4157668-8 |
689 | 0 | 2 | |a Fettsäuren |D s |0 (DE-588)4154233-2 |
689 | 0 | |5 AT-OBV |5 ONBREB | |
856 | 4 | 2 | |m V:AT-OBV;B:AT-UBMUW |q application/pdf |u http://media.obvsg.at/AC02934439-1001 |x ZBM |3 Inhaltsverzeichnis |o OBV-EDOC |
970 | 1 | |c 34 | |
970 | 2 | |a ZBM |d HS-DISS | |
ADM | |b 2024-03-23 11:37:34 Europe/Vienna |d 20 |f System |c marc21 |a 2018-12-24 09:50:25 Europe/Vienna |g false | ||
HOL | 8 | |b YWOAW |h 28705-C.Stip. |c MAG1-3 |8 2221756330004498 | |
852 | 8 | |b YWOAW |c MAG1-3 |h 28705-C.Stip. |8 2221756330004498 | |
ITM | |9 2221756330004498 |e 1 |m BOOK |b +YW707302 |i 2000:463 |2 MAG1-3 |o 20000322 |8 2321756300004498 |f 02 |p 2000-03-22 01:00:00 Europe/Vienna |h 28705-C.Stip. |1 YWOAW |q 2022-06-09 11:44:14 Europe/Vienna |